Predictive factors associated with invasive lobular breast cancer after neoadjuvant chemotherapy

被引：0
|
作者：
Julian, T. B.
Anderson, S.
Fourchotte, V.
Zieger, S.
Mamounas, E.
Bear, H.
Costantino, J.
Wolmark, N.
机构：
[1] NSABP, Ctr Biostat, Pittsburgh, PA USA
[2] Aultman Hosp, Canton, OH USA
[3] Virginia Commonwealth Univ, Richmond, VA USA
[4] Operat Ctr & Allegheny Gen Hosp, NSABP, Pittsburgh, PA USA
来源：
ANNALS OF SURGICAL ONCOLOGY | 2007年 / 14卷 / 02期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：17 / 17
页数：1
相关论文
共 50 条
  • [41] Discussion of: Neoadjuvant systemic therapy in invasive lobular breast cancer: Is it indicated?
    Sener, Stephen
    Tsung, Karen
    AMERICAN JOURNAL OF SURGERY, 2018, 215 (03): : 513 - 514
  • [42] Successful Breast Conservation After Neoadjuvant Chemotherapy in Lobular Breast Cancer: The Role of Menopausal Status in Response to Treatment
    Kirithiga Ramalingam
    Elle Clelland
    Harriet Rothschild
    Firdows Mujir
    Helena Record
    Mandeep Kaur
    Rita A. Mukhtar
    Annals of Surgical Oncology, 2023, 30 : 7099 - 7106
  • [43] Successful Breast Conservation After Neoadjuvant Chemotherapy in Lobular Breast Cancer: The Role of Menopausal Status in Response to Treatment
    Ramalingam, Kirithiga
    Clelland, Elle
    Rothschild, Harriet
    Mujir, Firdows
    Record, Helena
    Kaur, Mandeep
    Mukhtar, Rita A.
    ANNALS OF SURGICAL ONCOLOGY, 2023, 30 (12) : 7099 - 7106
  • [44] Predictive biomarkers of benefit from chemotherapy in invasive lobular carcinoma of the breast.
    Bilani, Nadeem
    Yaghi, Marita
    Jabbal, Iktej Singh
    Rivera, Carlos
    Dominguez, Barbara
    Li, Hong
    Nahleh, Zeina A.
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
  • [45] Response Rates of Invasive Lobular Cancer in Patients Undergoing Neoadjuvant Endocrine or Chemotherapy
    Jakub, James W.
    Zhang, Wenexia
    Solanki, Malvika
    Yonkus, Jennifer
    Boughey, Judy C.
    Harmsen, Scott
    Giridhar, Karthik, V
    AMERICAN SURGEON, 2023, 89 (02) : 230 - 237
  • [46] Response rates of patients with invasive lobular cancer undergoing neoadjuvant endocrine or chemotherapy
    Giridhar, Karthik
    Zhang, Wenxia
    Solanki, Malvika
    Boughey, Judy
    Yonkus, Jennifer
    Harmsen, William
    Jakub, James
    ANNALS OF SURGICAL ONCOLOGY, 2022, 29 (SUPPL 1) : 195 - 196
  • [47] Mammographic findings in microcalcifications associated with breast cancer after neoadjuvant chemotherapy
    Noguera, J. J.
    de Luisa, E.
    Alonso-Burgos, A.
    Viteri, S.
    Zornoza, G.
    Pina, L.
    RADIOLOGIA, 2007, 49 (01): : 37 - 41
  • [48] The predictive potential of Neuronatin for neoadjuvant chemotherapy of breast cancer
    Pieper, Willi
    Ignatov, Atanas
    Kalinski, Thomas
    Haybaeck, Johannes
    Czapiewski, Piotr
    Nass, Norbert
    CANCER BIOMARKERS, 2021, 32 (02) : 161 - 173
  • [49] Predictive markers of response to neoadjuvant chemotherapy in breast cancer
    Tewari, Mallika
    Krishnamurthy, Arvind
    Shukla, Hari S.
    SURGICAL ONCOLOGY-OXFORD, 2008, 17 (04): : 301 - 311
  • [50] Predictive Biomarkers in Breast Cancer: Their Value in Neoadjuvant Chemotherapy
    Fuksa, L.
    Micuda, S.
    Grim, J.
    Ryska, A.
    Hornychova, H.
    CANCER INVESTIGATION, 2012, 30 (09) : 663 - 678
12345